Table 2. Patients demographic and tumor characteristics.
| Characteristic | Total | H&NC | CRC | ESOC | GC | NSCLC | Others | |
|---|---|---|---|---|---|---|---|---|
| n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | ||
| Sex | Male | 139(67.8) | 26(76.5) | 48(67.6) | 21(100) | 24(68.6) | 16(69.6) | 4(19) |
| Female | 66(32.2) | 8 (23.5) | 23(32.4) | 0 | 11(31.4) | 7(30.4) | 17(81) | |
| Age (yr) | <60 | 137(66.8) | 23(67.6) | 46(64.8) | 9(42.9) | 23(65.7) | 16(69.6) | 20(95.2) |
| ≥60 | 68(33.2) | 11(32.4) | 25(34.7) | 12(57.1) | 12(34.3) | 7(30.4) | 1(4.8) | |
| Histopathology | ADC | 140(68.3) | 2(5.9) | 71(100) | 0 | 33(94.3) | 14(60.9) | 20(95.2) |
| Non-ADC | 65(31.7) | 32(94.1) | 0 | 21(100) | 2(5.7) | 9(39.1) | 1(4.8) | |
| Clinical stage | III | 5(2.4) | 2(5.9) | 0 | 1(4.8) | 0 | 2(8.7) | 0 |
| IV | 200(97.6) | 32(94.1) | 71(100) | 20(95.2) | 35(100) | 21(91.3) | 21(100) | |
| Previous treatment | ||||||||
| Surgery | NO | 82(40.0) | 21(61.8) | 15(21.1) | 11(52.4) | 20(57.1) | 13(56.5) | 2(9.5) |
| YES | 123(60.0) | 13(38.2) | 56(78.9) | 10(47.6) | 15(42.9) | 10(43.5) | 19(90.5) | |
| RT/CRT | NO | 115(56.1) | 8(23.5) | 47(66.2) | 5(23.8) | 32(91.4) | 13(56.5) | 10(47.6) |
| YES | 90(43.9) | 26(76.5) | 24(33.8) | 16(76.2) | 3(8.6) | 10(43.5) | 11(52.4) | |
| CT | NO | 40(19.5) | 18(52.9) | 9(12.7) | 5(23.8) | 5(14.3) | 1(4.3) | 2(9.5) |
| YES | 165(80.5) | 16(47.1) | 62(87.3) | 16(76.2) | 30(85.7) | 22(95.7) | 19(90.5) | |
H&NC: head and neck cancer; CRC: colorectal cancer; ESOC: esophageal cancer; GC: gastric cancer; NSCLC: non small cell lung cancer; n: number of patients.
ADC: adenocarcinoma; Non-ADC: squamous cell carcinoma or adeno-squamous carcinoma; RT: radiotherapy; CT: chemotherapy; CRT: chemoradiotherapy.